PIPorton

Pathogen Immunology Group at UKHSA, Porton. Work on GBS, Pertussis, Neisseria, NTHi, TB, Vaccines for AMR, Mucosal Immunity. Views not representative of UKHSA

[World Health Organization (WHO) @WHO]

🆕 #Tuberculosis, also known as TB, resurged as the leading infectious disease killer in 2023.

Approximately 8.2 million people were newly diagnosed with #TB in 2023 – the highest number recorded since WHO began global TB monitoring in 1995 https://t.co/77FMSBRmkr

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

The lack of access to safe and effective #antibiotics contributes to the emergence and spread of #AMR.

Learn more about antibiotic drug shortages and strategies employed to manage them in this systematic review, co-authored by GARDP’s @JenniferCohn2

👉https://t.co/tCIsQ1pWVz

[PIPorton @PiPorton]

Standing room only for the excellent Vaccines for AMR sessions at @vaccinenation World Vaccine Congress. Good to see such focus for these important global health goals.

And our scientific lead @Dr_SCT even managed to sneak himself onto the panel #WVCEU

[PIPorton @PiPorton]

Congrats to Stephanie Leung and the team. Nice to see such a lot of work finally out

Development of A Standardized Opsonophagocytosis Killing Assay for Group B Streptococcus and Assessment in an Interlaboratory Study https://t.co/sHcq3hx479 #mdpivaccines via @MDPIOpenAccess

[TB_BaconLab @TB_Baconlab]

TB Challenges workshop yesterday - sharing of technologies and forging of new collaborations to fight TB. Co-organised by @GoodFriendBigM and @TB_Baconlab hosted at university of Southampton, funded by @ukbiofilms.

[PIPorton @PiPorton]

Another lovely output from our collaboration with @TB_BaconLab & @Dr_luke_a
TB, biofilms, carbohydrates and complement. What’s not to love?
https://t.co/fo6jRofqJu

[PIPorton @PiPorton]

A great study to be involved with.

By inducing a broad immunogenic response effective against both PRN(+) and PRN(-) strains, BPZE1 has once again demonstrated the ability to address important immunologic limitations of current pertussis vaccines. https://t.co/wpLLactnxU

[AD3, UKHSA @HealthcareUKHSA]

Well done to our first year PhD student @BethanyKTMartin on presenting at NAMRIP

[Stop TB Partnership @StopTB]

“We @StopTB welcome the updated pricing of #GeneXpert diagnostic system which tests for both #COVID19 and TB. Great news for countries planning simultaneous integrated testing (https://t.co/BBZRUx4enO) for these 2 airborne diseases.”
📌📄Read https://t.co/SNW6NwQUlF @CepheidNews

[TB_BaconLab @TB_Baconlab]

Preprint now out -
M.tb biofilms modulate complement by reducing their carbs..

A fab collaboration with @Dr_SCT, @PiPorton, & @Dr_luke_a

https://t.co/lcGHRRgLlO

[Rare and Imported Pathogens Laboratory (RIPL) @RIPL_Porton]

A few permanent and fixed term vacancies now available in RIPL:

Senior BMS and LSO (permanent)
https://t.co/GzRH7qNsoD

Specialist BMS (2x fixed term)
https://t.co/e9ORk4odXY

MLA (permanent)
https://t.co/4Z0lSNILgO

New year, new job?

#ibmschat @IBMScience

[PIPorton @PiPorton]

Oxford vaccine phase I/II paper including our antibody-dependent complement activation assay is now out.

It's a great assay. If anyone is interested in extra functional data for their covid studies get in touch

https://t.co/7HXYPPkMFo

[PIPorton @PiPorton]

Just finished your BSc or MSc and looking for a start in research?

We have two entry level Research Scientists posts (1yr fixed term) in the Pathogen Immunology team at PHE Porton, primarily focussing on functional immunology of pertussis and covid .

https://t.co/s1EctPe8Fa

[PIPorton @PiPorton]

Congratulations @LabPinto. We're really looking forward to working with you and your team

[BactiVac Network @BactiVac]

Congratulations to all @BactiVac Pump-Priming Round 4 Awardees: Tatiana de Castro Abreu Pinto, Nopadon Pirarat, Qibo Zhang, @DrImranSaleem1 and @SeanetteWilson . #BactiVacFunding. https://t.co/PR8JTBMHjD

[PIPorton @PiPorton]

With today's news of the Oxford vaccine, just like to say great big thank you to all our team (and everyone else at Porton) that have worked themselves to exhaustion supporting this vaccine

You're all stars!

[PIPorton @PiPorton]

We have three research scientist immunology posts open in our fab team here at Porton (1yr fixed), working across a variety of topics from Group B Streptococcus vaccines & Haemophilus influenzae through to SARS-CoV-2.

Come join us, you'll love it !

https://t.co/oErojp7fMr

[AD3, UKHSA @HealthcareUKHSA]

We have 3 LiDo PhD projects on offer for oct2021, including this one, examining platelet populations in sepsis patients
https://t.co/CQyMiE7rAG

[James Mason @DrJamesMason]

We have a new, fully funded @BBSRC @LIDo_DTP PhD opportunity together with @HealthcarePhe as we develop a new class of therapeutic #antimicrobialpeptides to combat #AntibioticResistance https://t.co/LcO5FPATuV Come and joins us @KCLcancer_pharm

[Stephen Taylor @Dr_SCT]

100,000th serology sample run through the @EUROIMMUN SARS-CoV-2 assay tonight!

Mammoth effort from all involved at PHE Porton that have given up their normal jobs to respond. Includes staff from @PiPorton @TB_Baconlab @HealthcarePhe & @asherichia's team among many others.

[PIPorton @PiPorton]

Now out......Bactericidal activity after acellular pertussis vaccination driving loss of pertactin.

https://t.co/a2RsG2OJFO